Orchestra BioMed Holdings annual shares outstanding
2020
2021
2022
2023
2024
2025
Orchestra BioMed Holdings Shares Outstanding History (OBIO)
Orchestra BioMed Holdings reported 57.0M shares outstanding at the end of fiscal 2025.
View full Orchestra BioMed Holdings company overviewOrchestra BioMed Holdings annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 57.0M | 18.8M | +49.32% |
| 2024 | 2024-12-31 | 38.2M | 2.4M | +6.76% |
| 2023 | 2023-12-31 | 35.8M | 15.6M | +77.22% |
| 2022 | 2022-12-31 | 20.2M | 15.7M | +353.66% |
| 2021 | 2021-12-31 | 4.5M | 0 | 0.00% |
| 2020 | 2020-12-31 | 4.5M | — | — |
Orchestra BioMed Holdings quarterly shares outstanding
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 60.1M | 21.5M | +55.54% |
| Q1 2026 | 2026-03-31 | 58.6M | 20.3M | +53.03% |
| Q4 2025 | 2025-12-31 | 57.0M | 18.8M | +49.32% |
| Q3 2025 | 2025-09-30 | 56.5M | 18.5M | +48.81% |
| Q2 2025 | 2025-06-30 | 38.6M | 2.8M | +7.87% |
| Q1 2025 | 2025-03-31 | 38.3M | 2.5M | +7.06% |
| Q4 2024 | 2024-12-31 | 38.2M | 2.4M | +6.76% |
| Q3 2024 | 2024-09-30 | 37.9M | 2.2M | +6.15% |
| Q2 2024 | 2024-06-30 | 35.8M | 81,564 | +0.23% |
| Q1 2024 | 2024-03-31 | 35.8M | 4.0M | +12.74% |
| Q4 2023 | 2023-12-31 | 35.8M | 15.6M | +77.22% |
| Q3 2023 | 2023-09-30 | 35.7M | 31.3M | +703.24% |
| Q2 2023 | 2023-06-30 | 35.7M | 31.3M | +703.21% |
| Q1 2023 | 2023-03-31 | 31.7M | 27.3M | +613.28% |
| Q4 2022 | 2022-12-31 | 20.2M | 15.7M | +353.66% |
| Q3 2022 | 2022-09-30 | 4.5M | 0 | 0.00% |
| Q2 2022 | 2022-06-30 | 4.5M | −876,355 | −16.45% |
| Q1 2022 | 2022-03-31 | 4.5M | −867,122 | −16.31% |
| Q4 2021 | 2021-12-31 | 4.5M | −856,322 | −16.14% |
| Q3 2021 | 2021-09-30 | 4.5M | −847,110 | −15.99% |
| Q2 2021 | 2021-06-30 | 5.3M | — | — |
| Q1 2021 | 2021-03-31 | 5.3M | — | — |
| Q4 2020 | 2020-12-31 | 5.3M | — | — |
| Q3 2020 | 2020-09-30 | 5.3M | — | — |
Orchestra BioMed Holdings shares outstanding trends
Over the last five reported fiscal years, Orchestra BioMed Holdings's shares outstanding moved from 4.5M to 57.0M, a change of 52.6M. The latest reported quarter, Q2 2026, shows 60.1M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Orchestra BioMed Holdings filings at SEC.gov ↗